The LHNP treatment led to a 60.4% decrease in PLK1 expression in the tumor site and significantly inhibited tumor growth and prolonged the median survival time from 29 days (saline treated) to 40 days in tumor-burdened mice. Here, PLK1 is linked to neoplasm.